The Pharmacy Times® Reimbursement resource center provides clinical news and articles, information about reimbursement for clinical pharmacy services.
What can we help you find?
The shift from fee-for-service to a value-based care payment model represents the growing understanding of the value of health care providers in improving overall patient outcomes.
Girish Dighe, PharmD, MS, explains the importance of change management within a closed-loop system.
Safety net providers, which historically work in underserved communities, have successfully petitioned state legislatures to take action on 340B 2-tier pricing.
Counties in Medicaid expansion states saw an 11% lower rate of heroin deaths and a 10% lower rate of deaths involving synthetic opioids compared with counties in non-expansion states.
The emergence of a new Medicare Advantage plan, Troy Medicare, offers much needed momentum to drive pharmacists’ services.
The rise in value-based reimbursement models has required oncology care providers to assume an unprecedented level of accountability.
The proposal, which is still largely conceptual, was a part of Newsom’s proposed 2020-2021 budget.1
The Supreme Court released their decision to review Rutledge v. Pharmaceutical Care Management Association, which could affect pharmacy benefits across the country.
A key demand was for the Ohio Department of Medicaid (ODM) to set a minimum reimbursement level and dispensing fees for Managed Medicaid, in order to ensure that pharmacies receive adequate reimbursement plans.
There are some basic tips or tricks to getting the most out of your insurance plan and to maintain the care patients are accustomed to.
Girish Dighe, PharmD, MS, explains why it's important to understand more than just the revenue integrity piece of the puzzle.
Jesse C. Dresser, Esq explains how DIR fees affect specialty pharmacists at the NASP Annual Meeting in Washington, DC.